Value of Emerging and Existing Pre-prophylaxis and Therapeutic Options for COVID-19 in Transplant Recipients: A Systematic Review of Economic Evaluations [0.03%]
移植受者中新兴和现有的先兆性和治疗性COVID-19选项的价值：经济评估的系统评价
Alyssa Grant,Dima Kabbani,Andrew Vuong et al.
Alyssa Grant et al.
Background: High-risk populations, including transplant recipients, are at increased risk of severe Coronavirus disease 2019 (COVID-19) outcomes. Certain treatments and pre-exposure prophylaxis (PrEP) have been approved t...
Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality [0.03%]
连续远程监测的预期成本及入院率降低以实现收支平衡所需达到的程度评估
Arendse Tange Larsen,Liza Sopina,Eske Kvanner Aasvang et al.
Arendse Tange Larsen et al.
Background/objective: Hospital-level care at home is gaining traction, but evidence on health economic implications remains limited. The aim of this study was to estimate expected costs of continuous remote monitoring of ...
A Cost-Analysis and Micro-Costing Study of the Man Van Project: Comparing Prostate-Specific Antigen Testing Via a Nurse-Led Mobile Service with Primary Care [0.03%]
基于护士的流动服务和初级保健的前列腺特异性抗原检测的成本分析与微观成本研究：个案研究แมนvanished van项目成本及微量成本分析研究：将基于护工的移动服务与基础护理进行对比，以进行前列腺特异性抗原检验
Masood Moghul,Deokhee Yi,Fionnuala Croft et al.
Masood Moghul et al.
Background: The Man Van project is designed to address health inequalities and barriers to accessing healthcare related to the early diagnosis of prostate cancer with novel community-based targeting of high-risk groups us...
Content Validity of Two Generic Preference-Based Measures in Retinitis Pigmentosa, Including X-Linked Retinitis Pigmentosa [0.03%]
两种通用基于偏好的量表在视网膜色素变性（包括X连锁视网膜色素变性）中的内容有效性
Louis S Matza,Timothy A Howell,Qiaoyi Zhang et al.
Louis S Matza et al.
Introduction: Retinitis pigmentosa (RP) is a group of retinal diseases characterized by night blindness and impairment in visual field and acuity. The most severe form of RP is X-linked RP (XLRP). The relevance of common ...
Incremental Disease Burden (Healthcare Costs and Resources) of Duchenne Muscular Dystrophy in the US: A Matched Cohort Analysis [0.03%]
美国杜氏肌营养不良症疾病负担（医疗费用和资源）的增量：匹配队列分析
Mena Scavina,Nate Posner,Patricia Dorling et al.
Mena Scavina et al.
Background: Duchenne muscular dystrophy (DMD) is a rare genetic condition that causes progressive muscle weakness and reduced life expectancy. Detailed economic studies on the impact of DMD disease burden, costs, and heal...
Cost-Effectiveness of RefluxStop Versus Nissen Fundoplication and Proton Pump Inhibitors for Refractory Gastroesophageal Reflux Disease: A Spanish Healthcare Perspective [0.03%]
从西班牙医疗保健的角度看，与尼森手术和质子泵抑制剂相比，抗反流支架RefuflStop治疗难治性胃食管反流病的成本效益分析
Sam Harper,Khanh Ha Bui,Stuart Mealing et al.
Sam Harper et al.
Background: Gastroesophageal reflux disease (GERD) affects 6.8 million individuals in Spain, incurring €56 million/year in healthcare costs. Standard-of-care treatment (SOC) in Spain includes medical management with prot...
Healthcare Cost Associated with an Acute Mental Healthcare Bundle in Pediatric Emergency Departments [0.03%]
儿科急诊部门急性精神卫生保健包的相关医疗费用
Lola Ibraimova,Amanda S Newton,Stephen B Freedman et al.
Lola Ibraimova et al.
Objective: To evaluate healthcare cost associated with a standardized mental healthcare bundle in two tertiary pediatric emergency departments (EDs) in Alberta, Canada. ...
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain [0.03%]
西班牙慢性炎症性脱髓鞘多发神经病患者免疫球蛋白维持治疗的成本分析
Sofía de Pedro,María Presa,Josep Gamez et al.
Sofía de Pedro et al.
Background/objective: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, immune-mediated disorder, which causes peripheral nervous system dysfunction. Guidelines recommend maintenance treatment with intra...
Transferable Exclusivity Extension Vouchers for Antimicrobials: Incentive Design, Implementation Challenges, and Policy Trade-Offs [0.03%]
抗生素可转让性排他延期券：激励设计、实施挑战及政策权衡
Mario García-Díaz,Jorge Mestre-Ferrándiz,Jaime Espín
Mario García-Díaz
Antimicrobial resistance (AMR) is one of the greatest threats to public health, and forecasts for 2050 are even worse. In response, the European Commission (EC) is proposing the Transferable Exclusivity Extension Voucher (TEEV), which aims ...
Cost Comparison of Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-eclampsia, Compared to Usual Care: The PARROT-2 Trial [0.03%]
重复进行胎盘生长因子检测与常规护理在疑似子痫前期妇女中的成本比较：PARROT-2试验
Alice Hurrell,Louise Webster,Jenie Sparkes et al.
Alice Hurrell et al.
Objectives: The aim was to evaluate health resource use and cost, and conduct a cost comparison of repeat placental growth factor (PlGF)-based testing for suspected pre-eclampsia, compared with usual care. ...